| scholarly article | Q13442814 |
| P50 | author | Vasilis Kosmoliaptsis | Q42539358 |
| Dermot Mallon | Q58210208 | ||
| P2093 | author name string | J Andrew Bradley | |
| Craig J Taylor | |||
| Sarah Peacock | |||
| Graham Knighton | |||
| Jessie Martin | |||
| P2860 | cites work | Complement is activated by IgG hexamers assembled at the cell surface | Q30409381 |
| Transplantation: Complementing donor-specific antibody testing | Q33877558 | ||
| Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation | Q34124202 | ||
| Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. | Q35027253 | ||
| IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury | Q36417907 | ||
| The complement-mediated prozone effect in the Luminex single-antigen bead assay and its impact on HLA antibody determination in patient sera | Q38036750 | ||
| Detection of alloantibody-mediated complement activation: A diagnostic advance in monitoring kidney transplant rejection? | Q38539302 | ||
| Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells | Q39876473 | ||
| The epitope recognized by pan-HLA class I-reactive monoclonal antibody W6/32 and its relationship to unusual stability of the HLA-B27/beta2-microglobulin complex | Q40771639 | ||
| Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information. | Q40990548 | ||
| The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation | Q41150961 | ||
| Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing. | Q41228171 | ||
| HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy | Q41635879 | ||
| Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis | Q42802250 | ||
| False-positive reactions against HLA class II molecules detected in Luminex single-antigen bead assays | Q42854881 | ||
| Improved Luminex-based human leukocyte antigen-specific antibody screening using dithiothreitol-treated sera | Q43266315 | ||
| The significance of pretransplant donor-specific antibodies reactive with intact or denatured human leucocyte antigen in kidney transplantation | Q43419051 | ||
| HLA antibody specification using single-antigen beads--a technical solution for the prozone effect | Q43914521 | ||
| The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes | Q44174433 | ||
| Influence of test technique on sensitization status of patients on the kidney transplant waiting list | Q44371693 | ||
| Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution | Q45185527 | ||
| Systematic comparison of four cell- and Luminex-based methods for assessment of complement-activating HLA antibodies | Q45332005 | ||
| Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies | Q46081845 | ||
| Complement-binding anti-HLA antibodies and kidney-allograft survival | Q46141053 | ||
| Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival. | Q47989446 | ||
| Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. | Q50618048 | ||
| Antibodies against denatured HLA class II molecules detected in luminex-single antigen assay. | Q50855051 | ||
| Post-transplant development of C1q-positive HLA antibodies and kidney graft survival. | Q51841126 | ||
| Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays. | Q53032138 | ||
| C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection. | Q53225887 | ||
| Denatured class I human leukocyte antigen antibodies in sensitized kidney recipients: prevalence, relevance, and impact on organ allocation. | Q53256332 | ||
| Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. | Q53659700 | ||
| Pretransplant Donor-Specific HLA Class-I and -II Antibodies Are Associated With an Increased Risk for Kidney Graft Failure | Q60182181 | ||
| Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients | Q81774381 | ||
| Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss | Q82554497 | ||
| C1q-Fixing Human Leukocyte Antigen Antibodies Are Specific for Predicting Transplant Glomerulopathy and Late Graft Failure After Kidney Transplantation | Q82659907 | ||
| Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation | Q82732578 | ||
| Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts | Q85575440 | ||
| The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients | Q85963365 | ||
| Complement component C3 activation: the leading cause of the prozone phenomenon affecting HLA antibody detection on single-antigen beads | Q87427905 | ||
| Determinants of C1q binding in the single antigen bead assay | Q88058283 | ||
| Questioning the added value of Luminex single antigen beads to detect C1q binding donor HLA-specific antibodies | Q88058291 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1206-1214 | |
| P577 | publication date | 2017-06-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies | |
| P478 | volume | 101 |
| Q39445381 | Application, technical issues, and interpretation of C1q for graft outcome |
| Q59807564 | Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients |
| Q47646739 | Complement (C1q) Binding De Novo Donor Specific Antibodies and Cardiac-Allograft Vasculopathy in Pediatric Heart Transplant Recipients |
| Q28075921 | Detection of HLA Antibodies in Organ Transplant Recipients - Triumphs and Challenges of the Solid Phase Bead Assay |
| Q93035787 | EDTA Treatment for Overcoming the Prozone Effect and for Predicting C1q Binding in HLA Antibody Testing |
| Q91936201 | Human Leucocyte Antigen Sensitisation and Its Impact on Transfusion Practice |
| Q91837466 | Immune Algorithm Optimization for Organ Transplantation in Poland |
| Q59807111 | Predicting Humoral Alloimmunity from Differences in Donor and Recipient HLA Surface Electrostatic Potential |
| Q30397251 | The Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies |
Search more.